![CME Programme CSHK mw_menu_data_5564_56eb2b174e5e3.jpg](https://cshk.org/site/CSHK/upload/mw_menu_data/file/mw_menu_data_5564_56eb2b174e5e3.jpg)
CME Programme
-
Non-Regular Activities
SGLT2 Inhibition: From Glycemic Control to CKD ManagementDate: 28/08/2023 Enquiries: Boehringer Ingelheim Hong Kong Limited CME Points Awarded: 1 point Remarks: Ms. Natalie Wong
2596 1320
natalie.wong@boehringer-ingelheim.com